Citigroup Maintains Buy on Exact Sciences, Raises Price Target to $130
Portfolio Pulse from richadhand@benzinga.com
Citigroup analyst Patrick Donnelly maintains a Buy rating on Exact Sciences (NASDAQ:EXAS) and raises the price target from $100 to $130.
June 22, 2023 | 1:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup maintains a Buy rating on Exact Sciences and raises the price target from $100 to $130.
Citigroup's maintained Buy rating and increased price target for Exact Sciences (EXAS) indicates a positive outlook for the stock. The higher price target suggests that the analyst believes the stock has potential for further growth in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100